Aqaseem Factory for Chemicals and Plastics Co.
TADAWUL:9539.SR
50.2 (SAR) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2024 Q2 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 93.48 | 76.211 | 38.105 | 74.62 | 37.31 | 79.273 | 39.637 | 61.237 | 30.619 | 53.145 | 26.573 | 45.579 | 22.789 |
| Cost of Revenue
| 71.732 | 54.75 | 27.375 | 56.81 | 28.405 | 63.008 | 31.259 | 49.455 | 24.486 | 42.087 | 20.59 | 34.134 | 16.83 |
| Gross Profit
| 21.749 | 21.461 | 10.73 | 17.809 | 8.905 | 16.265 | 8.377 | 11.783 | 6.132 | 11.059 | 5.982 | 11.445 | 5.959 |
| Gross Profit Ratio
| 0.233 | 0.282 | 0.282 | 0.239 | 0.239 | 0.205 | 0.211 | 0.192 | 0.2 | 0.208 | 0.225 | 0.251 | 0.261 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 2.337 | 2.337 | 1.672 | 1.672 | 1.749 | 1.749 | 1.146 | 1.146 | 0.992 | 0.992 | 0.711 | 0.711 |
| Selling & Marketing Expenses
| 0 | 5.538 | 5.538 | 3.758 | 3.758 | 4.388 | 4.388 | 3.626 | 3.626 | 2.366 | 2.366 | 3.034 | 3.034 |
| SG&A
| 14.213 | 7.875 | 7.875 | 5.431 | 5.431 | 11.302 | 6.137 | 9.544 | 4.772 | 6.718 | 3.359 | 7.49 | 3.745 |
| Other Expenses
| 0 | -15.054 | 0 | -11.557 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 14.213 | 15.054 | 7.327 | 11.557 | 5.412 | 11.302 | 5.606 | 9.544 | 4.819 | 6.718 | 3.808 | 7.49 | 3.809 |
| Operating Income
| 7.535 | 6.407 | 3.099 | 6.252 | 3.231 | 4.963 | 2.482 | 2.239 | 1.119 | 4.341 | 2.171 | 3.955 | 1.977 |
| Operating Income Ratio
| 0.081 | 0.084 | 0.081 | 0.084 | 0.087 | 0.063 | 0.063 | 0.037 | 0.037 | 0.082 | 0.082 | 0.087 | 0.087 |
| Total Other Income Expenses Net
| -1.915 | -6.407 | -0.647 | -6.252 | -0.105 | -0.042 | -0.021 | -0.154 | -0.077 | -0.39 | -0.195 | 0.006 | 0.003 |
| Income Before Tax
| 5.621 | 2.451 | 2.451 | 3.126 | 3.126 | 4.922 | 2.461 | 2.085 | 1.042 | 3.951 | 1.976 | 3.961 | 1.98 |
| Income Before Tax Ratio
| 0.06 | 0.032 | 0.064 | 0.042 | 0.084 | 0.062 | 0.062 | 0.034 | 0.034 | 0.074 | 0.074 | 0.087 | 0.087 |
| Income Tax Expense
| 0.612 | -4.366 | 0.268 | 0.24 | 0.24 | 0.614 | 0.307 | 0.372 | 0.186 | 0.692 | 0.346 | 0 | 0 |
| Net Income
| 5.009 | 4.366 | 2.183 | 5.772 | 2.886 | 4.307 | 2.154 | 1.713 | 0.856 | 3.259 | 1.63 | 3.961 | 1.98 |
| Net Income Ratio
| 0.054 | 0.057 | 0.057 | 0.077 | 0.077 | 0.054 | 0.054 | 0.028 | 0.028 | 0.061 | 0.061 | 0.087 | 0.087 |
| EPS
| 2 | 1.75 | 0.87 | 20.42 | 1.15 | 1.72 | 0.86 | 0.69 | 0.34 | 1.3 | 0.652 | 1.58 | 0.792 |
| EPS Diluted
| 2 | 1.75 | 0.87 | 1.15 | 1.15 | 1.72 | 0.86 | 0.69 | 0.34 | 1.3 | 0.652 | 1.58 | 0.792 |
| EBITDA
| 10.032 | 10.773 | 3.647 | 3.684 | 3.684 | 6.39 | 2.95 | 3.667 | 1.592 | 6.17 | 2.632 | 5.352 | 2.439 |
| EBITDA Ratio
| 0.107 | 0.141 | 0.096 | 0.049 | 0.099 | 0.081 | 0.074 | 0.06 | 0.052 | 0.116 | 0.099 | 0.117 | 0.107 |